UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A role for cannabinoid CB1 receptors in mood and anxiety disorders

Behavioural pharmacology, 2005-09, Vol.16 (5-6), p.315-331

2005

Volltextzugriff (PDF)

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

Molecular psychiatry, 2006-02, Vol.11 (2), p.187-195

2006

Volltextzugriff (PDF)

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2 M4 muscarinic receptor knockout mice

Molecular psychiatry, 2003-07, Vol.8 (7), p.673-679

2003

Volltextzugriff (PDF)

In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder

The Journal of pharmacology and experimental therapeutics, 2013-02, Vol.344 (2), p.501

2013

Volltextzugriff (PDF)

Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants

Neuroscience, 2007-02, Vol.144 (4), p.1470-1476

2007

Volltextzugriff (PDF)

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinol

British journal of pharmacology, 1998-12, Vol.125 (7), p.1567-1577

1998

Volltextzugriff (PDF)

The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition

Molecular psychiatry, 2006-07, Vol.11 (7), p.619-621

2006

Volltextzugriff (PDF)

Diverse Psychotomimetics Act through a Common Signaling Pathway

Science (American Association for the Advancement of Science), 2003-11, Vol.302 (5649), p.1412-1415

2003

Volltextzugriff (PDF)

Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action

The Journal of neuroscience, 2003-10, Vol.23 (28), p.9374-9384

2003

Volltextzugriff (PDF)

Involvement of Striatal and Extrastriatal DARPP-32 in Biochemical and Behavioral Effects of Fluoxetine (Prozac)

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (5), p.3182-3187

2002

Volltextzugriff (PDF)

Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications

Biological psychiatry (1969), 2006-03, Vol.59 (6), p.508-515

2006

Volltextzugriff (PDF)

DARPP-32 Mediates Serotonergic Neurotransmission in the Forebrain

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (5), p.3188-3193

2002

Volltextzugriff (PDF)

Diurnal Variation of the Adenylyl Cyclase Type 1 in the Rat Pineal Gland

Proceedings of the National Academy of Sciences - PNAS, 1996-10, Vol.93 (20), p.11208-11212

1996

Volltextzugriff (PDF)

Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum

The European journal of neuroscience, 2000-03, Vol.12 (3), p.1038-1046

2000

Volltextzugriff (PDF)

Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study

Brain research, 2004-04, Vol.1005 (1), p.117-123

2004

Volltextzugriff (PDF)

The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia

Neuropharmacology, 2019-03, Vol.146, p.74-83

2019

Volltextzugriff (PDF)

In Vivo Occupancy of Dopamine D 3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder

The Journal of pharmacology and experimental therapeutics, 2013-02, Vol.344 (2), p.501-510

2013

Volltextzugriff (PDF)

Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation

The Journal of neuroscience, 2007-04, Vol.27 (15), p.4201-4209

2007

Volltextzugriff (PDF)

Effects of cannabinoids in Krox-24 targeted mice

Neuroreport, 2001-05, Vol.12 (7), p.1367-1370

2001

Volltextzugriff (PDF)

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

British journal of pharmacology, 2003-02, Vol.138 (4), p.544-553

2003

Volltextzugriff (PDF)

Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody

The Journal of clinical investigation, 2006-03, Vol.116 (3), p.825-832

2006

Volltextzugriff (PDF)

Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice

The Journal of neuroscience, 2005-01, Vol.25 (4), p.914-922

2005

Volltextzugriff (PDF)

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders

Trends in pharmacological sciences (Regular ed.), 2005-12, Vol.26 (12), p.609-617

2005

Volltextzugriff (PDF)

M 4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

The FASEB journal, 2004-09, Vol.18 (12), p.1410-1412

2004

Volltextzugriff (PDF)

Selective cortical VGLUT1 increase as a marker for antidepressant activity

Neuropharmacology, 2005-11, Vol.49 (6), p.890-900

2005

Volltextzugriff (PDF)

1 – 25 von 120

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(89)
Animals
(39)
Male
(39)
Public, Environmental & Occupational Health
(38)
Humans
(33)
Tobacco
(33)
Smoking
(32)
Polls & Surveys
(28)
Neurosciences & Neurology
(24)
Mice
(23)
Biological And Medical Sciences
(22)
Neurosciences
(22)
Cigarettes
(21)
Female
(20)
Public Health
(19)
Substance Abuse
(19)
Medical Sciences
(18)
Adult
(17)
Middle Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A role for cannabinoid CB1 receptors in mood and anxiety disorders

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2 M4 muscarinic receptor knockout mice

In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder

Calcineurin (protein phosphatase 2B) is involved in the mechanisms of action of antidepressants

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ‐9‐tetrahydrocannabinol

The procholinergic effects of the atypical antipsychotic olanzapine are independent of muscarinic autoreceptor inhibition

Diverse Psychotomimetics Act through a Common Signaling Pathway

Biphasic Effects of Cannabinoids on Acetylcholine Release in the Hippocampus: Site and Mechanism of Action

Involvement of Striatal and Extrastriatal DARPP-32 in Biochemical and Behavioral Effects of Fluoxetine (Prozac)

Endocannabinoids Activate Transient Receptor Potential Vanilloid 1 Receptors to Reduce Hyperdopaminergia-Related Hyperactivity: Therapeutic Implications

DARPP-32 Mediates Serotonergic Neurotransmission in the Forebrain

Diurnal Variation of the Adenylyl Cyclase Type 1 in the Rat Pineal Gland

Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum

Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study

The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia

In Vivo Occupancy of Dopamine D 3 Receptors by Antagonists Produces Neurochemical and Behavioral Effects of Potential Relevance to Attention-Deficit–Hyperactivity Disorder

Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation

Effects of cannabinoids in Krox-24 targeted mice

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody

Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders

M 4 muscarinic receptors regulate the dynamics of cholinergic and dopaminergic neurotransmission: relevance to the pathophysiology and treatment of related central nervous system pathologies

Selective cortical VGLUT1 increase as a marker for antidepressant activity

Suchergebnisse filtern